• 1
    Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55: 1030. Erratum in: CA Cancer J Clin. 2005;55:259.
  • 2
    El Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004; 39: 798803.
  • 3
    Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child. 1956; 91: 168186.
  • 4
    Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980; 46: 372379.
  • 5
    Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997; 26: 877883.
  • 6
    Lau WY. Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y. Surgery of the liver and biliary tract, 3rd ed. London: W.B. Saunders, 2000: 14231450.
  • 7
    McLarney JK, Rucker PT, Bender GN, Goodman ZD, Kashitani N, Ros PR. Fibrolamellar carcinoma of the liver: radiologic–pathologic correlation. Radiographics. 1999; 19: 453471.
  • 8
    Collier NA, Weinbren K, Bloom SR, Lee YC, Hodgson HJ, Blumgart LH. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet. 1984; 1: 538540.
  • 9
    Paradinas FJ, Melia WM, Wilkinson ML, et al. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. BMJ. 1982; 285: 840842.
  • 10
    Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg. 1986; 151: 518523.
  • 11
    Berman JJ. Correspondence re: A. G. Nerlich, S. Majewski, N. Hunzelmann, R. E. Brenner, B. Wiebecke, P. K. Muller, T. Krieg, K. Remberger. Distinctive case. Excessive collagen formation in fibrolamellar carcinoma of the liver: a morphological and biochemical study. Mod Pathol. 5: 580, 199. Mod Pathol. 1993; 6: 505–507.
  • 12
    Starzl TE, Iwatsuki S, Shaw BW Jr., Nalesnik MA, Farhi DC, Van Thiel DH. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet. 1986; 162: 145148.
  • 13
    Nagorney DM, Adson MA, Weiland LH, Knight CD Jr., Smalley SR, Zinsmeister AR. Fibrolamellar hepatoma. Am J Surg. 1985; 149: 113119.
  • 14
    Ringe B, Wittekind C, Weimann A, Tusch G, Pichlmayr R. Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet. 1992; 175: 299305.
  • 15
    Hemming AW, Langer B, Sheiner P, Greig PD, Taylor BR. Aggressive surgical management of fibrolamellar hepatocellular carcinoma. J Gastroinst Surg. 1997; 1: 342346.
  • 16
    Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet. 1957; 105: 310318.
  • 17
    Couinaud C. [ Anatomic principles of left and right regulated hepatectomy: technics]. J Chir (Paris). 1954; 70: 933966. French.
  • 18
    Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002; 20: 15271536.
  • 19
    Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 20
    Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999; 229: 790799.
  • 21
    Ichikawa T, Federle MP, Grazioli L, Marsh W. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology. 2000; 217: 145151.
  • 22
    Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology. 1999; 213: 352361.
  • 23
    Blachar A, Federle MP, Ferris JV, et al. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology. 2002; 223: 532539.
  • 24
    Perez-Guillermo M, Masgrau NA, Garcia-Solano J, de A Sola-Perez J, de Agustin y de Agustin P. Cytologic aspect of fibrolamellar hepatocellular carcinoma in fine-needle aspirates. Diagn Cytopathol. 1999; 21: 180187.
  • 25
    El Gazzaz G, Wong W, El Hadary MK, et al. Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int. 2000; 13(Suppl 1): S406S409.
  • 26
    Schlitt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol. 1999; 17: 324331.
  • 27
    Durand F, Belghiti J. Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology. 2002; 49: 4752.
  • 28
    Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999; 22: 2228.
  • 29
    Patt YZ, Hassan MM, Lozano RD, et al. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol. 2003; 21: 421427.